We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 29, 2020

Panitumumab Monotherapy in Chemotherapy‐Naïve Elderly Patients With Unresectable RAS Wild‐Type Colorectal Cancer

The Oncologist


Additional Info

Disclosure statements are available on the authors' profiles:

The Oncologist
Phase II Study of Panitumumab Monotherapy in Chemotherapy‐Naïve Frail or Elderly Patients With Unresectable RAS Wild‐Type Colorectal Cancer: OGSG 1602
Oncologist 2020 Sep 12;[EPub Ahead of Print], T Terazawa, T Kato, M Goto, al

Further Reading